337
Views
12
CrossRef citations to date
0
Altmetric
Original Research

From benzalkonium chloride-preserved Latanoprost to Polyquad-preserved Travoprost: a 6-month study on ocular surface safety and tolerability

, MD, , MD, , MD, , MD & , MD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Michele Figus, Luca Agnifili, Manuela Lanzini, Lorenza Brescia, Francesco Sartini, Leonardo Mastropasqua & Chiara Posarelli. (2021) Topical preservative-free ophthalmic treatments: an unmet clinical need. Expert Opinion on Drug Delivery 18:6, pages 655-672.
Read now

Articles from other publishers (11)

Nathan M. Radcliffe, Manjool Shah & Thomas W. Samuelson. (2023) Challenging the "Topical Medications-First” Approach to Glaucoma: A Treatment Paradigm in Evolution. Ophthalmology and Therapy 12:6, pages 2823-2839.
Crossref
Michele Figus, Matteo Sacchi, Gemma Caterina Rossi, Silvia Babighian, José Manuel Benitez Del Castillo, Laura de Polo, Eugenio Melchionda & Chiara Posarelli. (2023) Ocular surface and glaucoma, a mutual relationship. Practical suggestions for classification and management. European Journal of Ophthalmology.
Crossref
Nupur Vasdev, Nakshatra Chaudhari, Suryanarayana Polaka, Kuldeep Rajpoot, Piyush Gondaliya, Adil Ali Sayyed, Pinaki Sengupta & Rakesh Kumar Tekade. (2023) Current progress in preservative-free topical ophthalmic formulations. Journal of Drug Delivery Science and Technology 79, pages 103996.
Crossref
Katia Iskandar, Loïc Marchin, Laurent Kodjikian, Maxime Rocher & Christine Roques. (2022) Highlighting the Microbial Contamination of the Dropper Tip and Cap of In-Use Eye Drops, the Associated Contributory Factors, and the Risk of Infection: A Past-30-Years Literature Review. Pharmaceutics 14:10, pages 2176.
Crossref
Fredrik Fineide, Neil Lagali, Muhammed Yasin Adil, Reiko Arita, Miriam Kolko, Jelle Vehof & Tor P. Utheim. (2022) Topical glaucoma medications – Clinical implications for the ocular surface. The Ocular Surface 26, pages 19-49.
Crossref
Michael H. Goldstein, Fabiana Q. Silva, Nysha Blender, Trung Tran & Srilatha Vantipalli. (2021) Ocular benzalkonium chloride exposure: problems and solutions. Eye 36:2, pages 361-368.
Crossref
Omer Ersin Muz, Kenan Dagdelen, Tuncay Pirdal & Mete Guler. (2021) Comparison of BAK-preserved latanoprost and polyquad-preserved travoprost on ocular surface parameters in patients with glaucoma and ocular hypertension. International Ophthalmology 41:11, pages 3825-3835.
Crossref
Tarek Shaarawy & Amr Aref. 2020. Periorbital Rejuvenation. Periorbital Rejuvenation 51 63 .
Xuemin Zhang, Saujanya Vadoothker, Wuqaas M. Munir & Osamah Saeedi. (2019) Ocular Surface Disease and Glaucoma Medications: A Clinical Approach. Eye & Contact Lens: Science & Clinical Practice 45:1, pages 11-18.
Crossref
Pierre Dubrulle, Antoine Labbé, Emmanuelle Brasnu, Hong Liang, Pascale Hamard, Lyes Meziani & Christophe Baudouin. (2018) Influence of Treating Ocular Surface Disease on Intraocular Pressure in Glaucoma Patients Intolerant to Their Topical Treatments: A Report of 10 Cases. Journal of Glaucoma 27:12, pages 1105-1111.
Crossref
Wissam Georges El Hajj Moussa, Rebecca Georges Farhat, Joseph Claud Nehme, Marwan Antoun Sahyoun, Alexandre Raymond Schakal, Alexandre Edmond Jalkh, Mariana Pierre Abi Karam & Georges Georges Azar. (2018) Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients. Journal of Ophthalmology 2018, pages 1-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.